Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2017/Astellas-and-Ironwood-Report-Positive-Top-Line-Results-from-Phase-III-Linaclotide-Trial-for-Patients-with-Chronic-Constipation-Conducted-in-Japan/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here